Discovery of mmu-lncRNA129814/hsa-lncRNA582795 as a Potential Biomarker and Intervention Target for Ischemia Reperfusion Injury-Induced AKI

References

• Demirjian S, Bashour CA, Shaw A, et al. Predictive accuracy of a perioperative laboratory test-based prediction model for moderate to severe acute kidney injury after cardiac surgery. JAMA. 2022;327(10):956–964. doi:10.1001/jama.2022.1751
   PubMed Web of Science ®Google Scholar
• Peng K, McIlroy DR, Bollen BA, et al. Society of cardiovascular anesthesiologists clinical practice update for management of acute kidney injury associated with cardiac surgery. Anesth Analg. 2022;135(4):744–756. doi:10.1213/ANE.0000000000006068
   PubMed Web of Science ®Google Scholar
• Tseng PY, Chen YT, Wang CH, et al. Prediction of the development of acute kidney injury following cardiac surgery by machine learning. Crit Care. 2020;24(1):478. doi:10.1186/s13054-020-03179-9
   PubMed Web of Science ®Google Scholar
• Li X, Zheng P, Ji T, Tang B, Wang Y, Bai S. LINC00052 ameliorates acute kidney injury by sponging miR-532-3p and activating the Wnt signaling pathway. Aging. 2020;13(1):340–350. doi:10.18632/aging.104152
   PubMedGoogle Scholar
• Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697–711. doi:10.1038/nrneph.2017.119
   PubMed Web of Science ®Google Scholar
• Zarbock A, Küllmar M, Ostermann M, et al. Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the prevaki-multicenter randomized controlled trial. Anesth Analg. 2021;133(2):292–302. doi:10.1213/ANE.0000000000005458
   PubMed Web of Science ®Google Scholar
• Lameire N, Biesen WV, Vanholder R. Acute kidney injury. Lancet. 2008;372(9653):1863–1865. doi:10.1016/S0140-6736(08)61794-8
   PubMed Web of Science ®Google Scholar
• Ayad S, Neylan JF, Mayne TJ, Gouveia D, Swaminathan M. Hepatocyte growth factor mimetic ANG-3777 for cardiac surgery-associated acute kidney injury. Kidney Int Rep. 2020;5(12):2325–2332. doi:10.1016/j.ekir.2020.09.031
   PubMed Web of Science ®Google Scholar
• Stoppe C, Averdunk L, Goetzenich A, et al. The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery. Sci Transl Med. 2018;10(441). doi:10.1126/scitranslmed.aan4886
   PubMed Web of Science ®Google Scholar
• Tiwari R, Kapitsinou PP. Role of endothelial prolyl-4-hydroxylase domain protein/hypoxia-inducible factor axis in acute kidney injury. Nephron. 2022;146(3):243–248. doi:10.1159/000518632
   PubMed Web of Science ®Google Scholar
• Endre ZH, Walker RJ, Pickering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int. 2010;77(11):1020–1030. doi:10.1038/ki.2010.25
   PubMed Web of Science ®Google Scholar
• Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25. doi:10.1186/cc12503
   PubMed Web of Science ®Google Scholar
• Parikh CR, Thiessen-Philbrook H, Garg AX, et al. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol. 2013;8(7):1079–1088. doi:10.2215/CJN.10971012
   PubMed Web of Science ®Google Scholar
• Koyner JL, Parikh CR. Clinical utility of biomarkers of AKI in cardiac surgery and critical illness. Clin J Am Soc Nephrol. 2013;8(6):1034–1042. doi:10.2215/CJN.05150512
   PubMed Web of Science ®Google Scholar
• Vandenberghe W, Van Laethem L, Herck I, et al. Prediction of cardiac surgery associated - acute kidney injury (CSA-AKI) by healthcare professionals and urine cell cycle arrest AKI biomarkers [TIMP-2]*[IGFBP7]: a single center prospective study (the PREDICTAKI trial). J Crit Care. 2022;67:108–117. doi:10.1016/j.jcrc.2021.10.015
   PubMed Web of Science ®Google Scholar
• Pan J, Xie Y, Li H, et al. mmu-lncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p/HtrA3 signaling axis. Mol Ther. 2022;30(12):3694–3713. doi:10.1016/j.ymthe.2022.07.014
   PubMed Web of Science ®Google Scholar
• Xue Q, Yang L, Wang H, Han S, Ramoji K. Silence of long noncoding RNA SNHG14 alleviates ischemia/reperfusion-induced acute kidney injury by regulating miR-124-3p/MMP2 axis. Biomed Res Int. 2021;2021:8884438. doi:10.1155/2021/8884438
   PubMed Web of Science ®Google Scholar
• Wang IK, Palanisamy K, Sun KT, et al. The functional interplay of lncRNA EGOT and HuR regulates hypoxia-induced autophagy in renal tubular cells. J Cell Biochem. 2020;121(11):4522–4534. doi:10.1002/jcb.29669
   PubMed Web of Science ®Google Scholar
• Chen F, Hu Y, Xie Y, et al. Total glucosides of paeony alleviate cell apoptosis and inflammation by targeting the long noncoding RNA XIST/MicroRNA-124-3p/ITGB1 axis in renal ischemia/reperfusion injury. Mediators Inflamm. 2020;2020:8869511. doi:10.1155/2020/8869511
   PubMed Web of Science ®Google Scholar
• Tang B, Li W, Ji T, et al. Downregulation of XIST ameliorates acute kidney injury by sponging miR-142-5p and targeting PDCD4. J Cell Physiol. 2020;235(11):8852–8863. doi:10.1002/jcp.29729
   PubMed Web of Science ®Google Scholar
• Geng X, Song N, Zhao S, et al. LncRNA GAS5 promotes apoptosis as a competing endogenous RNA for miR-21 via thrombospondin 1 in ischemic AKI. Cell Death Discov. 2020;6(1):19. doi:10.1038/s41420-020-0253-8
   PubMed Web of Science ®Google Scholar
• Tian X, Ji Y, Liang Y, Zhang J, Guan L, Wang C. LINC00520 targeting miR-27b-3p regulates OSMR expression level to promote acute kidney injury development through the PI3K/AKT signaling pathway. J Cell Physiol. 2019;234(8):14221–14233. doi:10.1002/jcp.28118
   PubMed Web of Science ®Google Scholar
• Liu D, Liu Y, Zheng X, Liu N. c-MYC-induced long noncoding RNA MEG3 aggravates kidney ischemia-reperfusion injury through activating mitophagy by upregulation of RTKN to trigger the Wnt/β-catenin pathway. Cell Death Dis. 2021;12(2):191. doi:10.1038/s41419-021-03466-5
   PubMed Web of Science ®Google Scholar
• Li X, Wu Z, Yang J, Zhang D. LncRNA 148400 promotes the apoptosis of renal tubular epithelial cells in ischemic AKI by targeting the miR-10b-3p/GRK4 axis. Cells. 2022;11(24):3986. doi:10.3390/cells11243986
   PubMed Web of Science ®Google Scholar
• Liu J, Li X, Yang J, Zhang D. LncRNA ENSMUST_147219 mediates the progression of ischemic acute kidney injury by targeting the miR-221-5p/IRF6 axis. Apoptosis. 2022;27(7–8):531–544. doi:10.1007/s10495-022-01730-3
   PubMed Web of Science ®Google Scholar
• Haddad G, Kölling M, Wegmann UA, et al. Renal AAV2-mediated overexpression of long non-coding RNA H19 attenuates ischemic acute kidney injury through sponging of microRNA-30a-5p. J Am Soc Nephrol. 2021;32(2):323–341. doi:10.1681/ASN.2020060775
   PubMed Web of Science ®Google Scholar
• Chen L, Xu JY, Tan HB. LncRNA TUG1 regulates the development of ischemia-reperfusion mediated acute kidney injury through miR-494-3p/E-cadherin axis. J Inflamm. 2021;18(1):12. doi:10.1186/s12950-021-00278-4
   Google Scholar
• Xie LB, Chen B, Liao X, et al. LINC00963 targeting miR-128-3p promotes acute kidney injury process by activating JAK2/STAT1 pathway. J Cell Mol Med. 2020;24(10):5555–5564. doi:10.1111/jcmm.15211
   PubMed Web of Science ®Google Scholar
• Xu J, Wang B, Zhang D. LncRNA ENSMUST00000171502 induced by HIF-1α ameliorates ischemic acute kidney injury via targeting the miR-130b-3p/Mybl-1 axis. Cells. 2022;11(23):3747. doi:10.3390/cells11233747
   PubMed Web of Science ®Google Scholar
• Nagulakonda S, Pandey NN, Arvind B, Kumar S. Levoatriocardinal vein in a patient with transposition of great arteries and pulmonary stenosis. J Card Surg. 2022;37(9):2837–2838. doi:10.1111/jocs.16682
   PubMed Web of Science ®Google Scholar
• Wu Z, Pan J, Yang J, Zhang D. LncRNA136131 suppresses apoptosis of renal tubular epithelial cells in acute kidney injury by targeting the miR-378a-3p/Rab10 axis. Aging. 2022;14(8):3666–3686. doi:10.18632/aging.204036
   PubMedGoogle Scholar
• Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118. doi:10.1038/s41580-020-00315-9
   PubMed Web of Science ®Google Scholar
• Xu J, Xu J, Liu X, Jiang J. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Cell Death Discov. 2022;8(1):287. doi:10.1038/s41420-022-01061-x
   PubMed Web of Science ®Google Scholar
• Wang T, Li P, Ma X, et al. MicroRNA-494 inhibition protects nucleus pulposus cells from TNF-α-induced apoptosis by targeting JunD. Biochimie. 2015;115:1–7. doi:10.1016/j.biochi.2015.04.011
   PubMed Web of Science ®Google Scholar
• Li H, Zhang L, Cai N, Zhang B, Sun S. MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3. Ann Hepatol. 2021;23:100305. doi:10.1016/j.aohep.2021.100305
   PubMed Web of Science ®Google Scholar
• Ning S, Li Z, Ji Z, et al. MicroRNA‑494 suppresses hypoxia/reoxygenation‑induced cardiomyocyte apoptosis and autophagy via the PI3K/AKT/mTOR signaling pathway by targeting SIRT1. Mol Med Rep. 2020;22(6):5231–5242. doi:10.3892/mmr.2020.11636
   PubMed Web of Science ®Google Scholar
• Cui R, Ye S, Zhong J, et al. MicroRNA‑494 inhibits apoptosis of murine vascular smooth muscle cells in vitro. Mol Med Rep. 2019;19(5):4457–4467. doi:10.3892/mmr.2019.10085
   PubMed Web of Science ®Google Scholar
• Wu C, Yang J, Li R, Lin X, Wu J, Wu J. LncRNA WT1-AS/miR-494-3p regulates cell proliferation, apoptosis, migration and invasion via PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer. Onco Targets Ther. 2021;14:891–904. doi:10.2147/OTT.S278233
   PubMed Web of Science ®Google Scholar
• Wang H, Wang S, Huang S. MiR-494-3p alleviates acute lung injury through regulating NLRP3 activation by targeting CMPK2. Biochem Cell Biol. 2021;99(3):286–295. doi:10.1139/bcb-2020-0243
   PubMedGoogle Scholar
• Hua J, Wang X, Ma L, et al. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis. Mol Cancer. 2022;21(1):123. doi:10.1186/s12943-022-01595-9
   PubMed Web of Science ®Google Scholar
• Mauro AG, Mezzaroma E, Torrado J, et al. Reduction of myocardial ischemia-reperfusion injury by inhibiting interleukin-1 alpha. J Cardiovasc Pharmacol. 2017;69(3):156–160. doi:10.1097/FJC.0000000000000452
   PubMed Web of Science ®Google Scholar
• Liberale L, Bonetti NR, Puspitasari YM, et al. Postischemic administration of IL-1α neutralizing antibody reduces brain damage and neurological deficit in experimental stroke. Circulation. 2020;142(2):187–189. doi:10.1161/CIRCULATIONAHA.120.046301
   PubMed Web of Science ®Google Scholar
• Wen Y, Parikh CR. The aftermath of AKI: recurrent AKI, acute kidney disease, and CKD progression. J Am Soc Nephrol. 2021;32(1):2–4. doi:10.1681/ASN.2020091317
   PubMed Web of Science ®Google Scholar
• Koyner JL. Subclinical acute kidney injury is acute kidney injury and should not be ignored. Am J Respir Crit Care Med. 2020;202(6):786–787. doi:10.1164/rccm.202006-2239ED
   PubMed Web of Science ®Google Scholar
• Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. doi:10.1038/s41572-021-00284-z
   PubMed Web of Science ®Google Scholar
• Huang CT, Liu KD. Exciting developments in the field of acute kidney injury. Nat Rev Nephrol. 2020;16(2):69–70. doi:10.1038/s41581-019-0241-5
   PubMed Web of Science ®Google Scholar
• Du J, Cao X, Zou L, et al. MicroRNA-21 and risk of severe acute kidney injury and poor outcomes after adult cardiac surgery. PLoS One. 2013;8(5):e63390.
   PubMed Web of Science ®Google Scholar
• Gaede L, Liebetrau C, Blumenstein J, et al. Plasma microRNA-21 for the early prediction of acute kidney injury in patients undergoing major cardiac surgery. Nephrol Dial Transplant. 2016;31(5):760–766. doi:10.1093/ndt/gfw007
   PubMed Web of Science ®Google Scholar
• Arvin P, Samimagham HR, Montazerghaem H, Khayatian M, Mahboobi H, Ghadiri Soufi F. Early detection of cardiac surgery‑associated acute kidney injury by microRNA-21. Bratisl Lek Listy. 2017;118(10):626–631. doi:10.4149/BLL_2017_120
   PubMed Web of Science ®Google Scholar
• Liu S, Cao Q, An G, Yan B, Lei L. Identification of the 3-lncRNA signature as a prognostic biomarker for colorectal cancer. Int J Mol Sci. 2020;21(24):9359. doi:10.3390/ijms21249359
   PubMed Web of Science ®Google Scholar
• Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2). doi:10.1083/jcb.202009045
   PubMed Web of Science ®Google Scholar
• Pilarczyk K, Edayadiyil-Dudasova M, Wendt D, et al. Urinary [TIMP-2]*[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery. Ann Intensive Care. 2015;5(1):50. doi:10.1186/s13613-015-0076-6
   PubMedGoogle Scholar
• Wang Y, Zou Z, Jin J, et al. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. BMC Nephrol. 2017;18(1):177. doi:10.1186/s12882-017-0592-8
   PubMedGoogle Scholar
• Titeca-Beauport D, Daubin D, Chelly J, et al. The urine biomarkers TIMP2 and IGFBP7 can identify patients who will experience severe acute kidney injury following a cardiac arrest: a prospective multicentre study. Resuscitation. 2019;141:104–110. doi:10.1016/j.resuscitation.2019.06.008
   PubMed Web of Science ®Google Scholar